EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Second Primary Malignancies in Patients with Colorectal Cancer: The Frequency, Types, and Timeline

Zlata Lerner iD, Sarah Weissmann, Heba Abu-Kaf, Ali Abu-Juma iD, Barah Abu Gnim iD, Naim Abu-Freha iD

Journal of Clinical Medicine · 28.01.2026 · 15 (3) · 1053

DOI: 10.3390/jcm15031053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.01.2026. Verfasst von Zlata Lerner und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Gastroenterology and Hepatology, Soroka University Medical Center, P.O. Box 151, Beer-Sheva 84101, Israel. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Colorectal cancer (CRC) is the third most common cancer worldwide. Accordingly, we aimed to investigate the frequency, types, and timelines of other cancers in patients diagnosed with CRC.

Methods

Patients diagnosed with CRC between 1999 and 2023 were retrospectively included. We collected data on the demographics and diagnosis of any additional cancer, either prior to or following the CRC diagnosis. Data were retrieved from the Clalit database using the MDClone platform.

Results

A total of 65,774 CRC patients were identified between 1999 and 2023. A second primary malignancy (SPM) was diagnosed in 13,679 patients (21%). Being female, smoking, and having chronic obstructive pulmonary disease were more frequent among patients with a SPM. Breast, prostate, and lung cancers were the most prevalent SPMs. The risk of developing SPM was highest during the first three years after CRC diagnosis, especially with respect to lung cancer, whereas the majority of breast and prostate cancers were diagnosed during the three years before CRC; the cumulative standardized incidence ratio was calculated to be 4.1 for any cancer.

Conclusions

CRC patients have an increased second primary cancer. Patients diagnosed with CRC should be encouraged to undergo screening for other cancers, and those with Lynch-related cancers should be investigated for the syndrome. Patients with a diagnosis of breast or prostate cancer should be considered for colonoscopy screening.

Schlagwörter

Stichwörter der Autor:innen

Lynch syndromebreast cancercolorectal cancerprostate cancersecond primary malignancy

Autor:innen und Institutionen

  • The Institute of Gastroenterology and Hepatology, Soroka University Medical Center, P.O. Box 151, Beer-Sheva 84101, Israel.
  • Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
  • Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

ORCID-Profile: Zlata Lerner, Ali Abu-Juma, Barah Abu Gnim, Naim Abu-Freha

Zitieren

APA

Lerner, Z., Weissmann, S., Abu-Kaf, H., Abu-Juma, A., Abu Gnim, B., & Abu-Freha, N. (2026). Second Primary Malignancies in Patients with Colorectal Cancer: The Frequency, Types, and Timeline. Journal of Clinical Medicine, 15(3), 1053. https://doi.org/10.3390/jcm15031053

Vancouver

Lerner Z, Weissmann S, Abu-Kaf H, Abu-Juma A, Abu Gnim B, Abu-Freha N. Second Primary Malignancies in Patients with Colorectal Cancer: The Frequency, Types, and Timeline. Journal of Clinical Medicine. 2026;15(3):1053. doi:10.3390/jcm15031053

BibTeX
@article{Lerner2026,
  author = {Lerner, Zlata and Weissmann, Sarah and Abu-Kaf, Heba and Abu-Juma, Ali and Abu Gnim, Barah and Abu-Freha, Naim},
  title = {Second Primary Malignancies in Patients with Colorectal Cancer: The Frequency, Types, and Timeline},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {1053},
  doi = {10.3390/jcm15031053}
}
Kostenlos starten →